Related references
Note: Only part of the references are listed.
Article
Biochemistry & Molecular Biology
Fan Deng et al.
Summary: This study found that propionate alleviates myocardial ischemia/reperfusion (I/R) injury aggravated by Ang II through the CAV-1/ACE2 axis dependent on GPR41. Propionate inhibits the elevation of Ang II levels, thereby reducing myocardial injury. This research provides a new direction for using diet to regulate intestinal flora for the treatment of myocardial I/R injury.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2022)
Article
Microbiology
Jingjuan Hu et al.
Summary: This study investigated the relationship between the gut microbiome and intestinal ischemia/reperfusion (I/R) injury. It found that Lactobacillus murinus can alleviate intestinal I/R injury in mice through macrophages, and this effect may be achieved by promoting the release of IL-10 from macrophages through TLR2. This study revealed a novel mechanism of intestinal I/R injury and provided a new therapeutic strategy for clinical practice.
Review
Immunology
Qihang Hou et al.
Summary: The mammalian intestine is the largest immune organ, containing intestinal stem cells (ISC), differentiated epithelial cells, and gut resident-immune cells. Inflammatory bowel disease (IBD) threatens intestinal integrity and the continuous renewal of intestinal mucosal epithelium relies on ISC. Targeting inflamed mucosa healing may improve clinical symptoms and disease recurrence in IBD patients. Recent findings suggest that immune cells and cytokines play critical roles in ISC and intestinal epithelium regeneration, paving the way for new therapeutic approaches such as ISC transplantation. Integration of biological agents and ISC transplantation could revolutionize future therapy for IBD patients.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Gastroenterology & Hepatology
Zhi Liu et al.
Summary: The study systematically explored the interplay between host genetic variation and gut microbiota in ASD children, finding that ASD SNVs were significantly enriched in specific genes and correlated with microbial composition and metabolism. The abundance of metabolites involved in the metabolic network of neurotransmitters was inferred to be causally related to specific SNVs and microbes, suggesting a crucial role of host genetics and gut microbes in immune and metabolism homeostasis in ASD.
Article
Gastroenterology & Hepatology
Yogesh Bhattarai et al.
Summary: Parkinson's disease is a common neurodegenerative disorder associated with alterations in gut microbiota and epithelial barrier function. In a mouse model, chronic rotenone treatment resulted in changes in gut microbiota composition and increased intestinal permeability, exacerbating motor deficits.
Article
Immunology
Chun-Yu Lin et al.
Summary: Exposure to DEHP was associated with gastrointestinal bleeding in DV-infected patients, while MEHP treatment led to changes in macrophage immune responses and DV viral load. The study revealed a negative correlation between urine sigma DEHP levels and serum IL-23 levels in patients, highlighting the potential impact of environmental hormones on dengue disease outcomes.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Microbiology
Laura de Nies et al.
Summary: PathoFact is a tool that accurately predicts virulence factors, bacterial toxins, and antimicrobial resistance genes in metagenomic data. It outperforms existing workflows in predicting virulence factors and toxin genes, and performs well in predicting antimicrobial resistance. This tool can be applied independently for each module, making it flexible and versatile.
Article
Microbiology
Yingli Jing et al.
Summary: Fecal microbiota transplantation (FMT) from healthy uninjured mice into SCI mice was found to improve locomotor and GI functions through promoting neuronal axonal regeneration, enhancing intestinal barrier integrity and modifying gut microbiome composition. Additionally, FMT increased levels of short-chain fatty acids (SCFAs) in feces and downregulated inflammatory signaling pathways in the spinal cord and gut of SCI mice. These findings suggest that FMT may have a neuroprotective effect on SCI.
Article
Immunology
Fan Deng et al.
Summary: The study demonstrates that pravastatin can attenuate intestinal I/R injury by promoting the release of IL-13 from ILC2s, revealing a novel mechanism and therapeutic strategy for intestinal I/R injury.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Microbiology
Hao-Yu Liu et al.
Summary: The study shows that oral administration of the probiotic bacterium Limosilactobacillus reuteri R2LC increases the numbers and effector functions of B cell subsets, leading to enhanced IgA production, altered intestinal microbiota, and protection against inflammation.
Article
Microbiology
Qi Zhao et al.
Summary: This study found that alterations in gut microbiota are linked to testicular dysfunction through disruption of polyamine metabolism. The diversity and dynamics of the gut microbiota may be considered as a therapeutic option to prevent male infertility.
Article
Microbiology
Fernando A. Vicentini et al.
Summary: The study demonstrates the role of the gut microbiota in regulating the structure and function of the GI tract in a sex-independent manner. The microbiota is essential for maintaining ENS integrity by regulating enteric neuronal survival and promoting neurogenesis. Molecular determinants such as LPS and SCFA play a key role in regulating enteric neuronal survival and neurogenesis.
Article
Immunology
Miaomiao Wu et al.
Summary: Research indicates that complement activation plays a critical role in intestinal ischemia reperfusion injury in a sex-dependent manner, with female mice tending to rely more on the lectin pathway while male mice use both the C1q and MBL pathways simultaneously. Females also produce significantly less serum C5a in response to the injury.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Microbiology
Qixin Han et al.
Summary: This study indicates that androgen-induced gut microbiota dysbiosis may exacerbate metabolic and endocrinal dysfunction in PCOS. Experimental results show that even with the elimination of gut microbiota, DHEA-treated rats still exhibit PCOS phenotypes. Transplantation of gut microbiota triggers disturbances in hepatic glucolipid metabolism and reproductive hormone imbalance.
Article
Microbiology
Sabrine Naimi et al.
Summary: The study found that many commonly used emulsifiers can directly alter the gut microbiota in a way that promotes intestinal inflammation. While some emulsifiers had similar impacts on the microbiota, others, such as lecithin, did not significantly affect the microbiota in the model. Various carrageenans and gums were found to have particularly detrimental impacts on microbiota density, composition, and expression of pro-inflammatory molecules.
Article
Microbiology
Dieter M. Tourlousse et al.
Summary: This study validated and standardized methodologies for DNA extraction and library construction, improving the accuracy and reproducibility of human fecal microbiota analysis. The provided best practice guidance enhances metagenomic research and facilitates the development and commercialization of human microbiome-based products.
Review
Immunology
Prashanta Silwal et al.
Summary: Autophagy plays a crucial role in enhancing the immune responses and controlling inflammation against NTM infections, and holds potential as a therapeutic target for combating NTM infections.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Immunology
Lupeng Chen et al.
Summary: This study demonstrates that the combination of konjac mannan oligosaccharides (KMOS) and Bacillus subtilis (BS) has a synergistic repair effect on inflammatory and oxidative damage of Caco-2 cells, as well as alleviates LPS-induced acute intestinal injury in mice. Co-treatment with KMOS and BS enhances the activity and antioxidant capacity of Caco-2 cells, protects mouse liver and ileum from oxidative damage, and repairs tight junction and mucus barrier damage.
FRONTIERS IN IMMUNOLOGY
(2021)
Review
Microbiology
Douglas V. Guzior et al.
Summary: Bile acids play key roles in gut metabolism, cell signaling, and microbiome composition. Microbes in the gut modify primary bile acids into diverse forms, and alterations in these secondary bile acids have been linked to various diseases. Recent studies have shown that gut microbiota can conjugate amino acids to bile acids, greatly increasing the diversity of bile acids in mammalian gut.
Article
Microbiology
Yusook Chung et al.
Summary: This study developed an effective bacterial drug delivery system for colorectal cancer therapy using the lactic acid bacterium Pediococcus pentosaceus, which significantly reduced tumor volume and inhibited tumor growth in mouse models. The synthetic probiotic also modulated gut microbiota and alleviated chemically induced dysbiosis, demonstrating the potential of cell-based designer biopharmaceuticals for treating CRC and restoring impaired microbiota.
Article
Microbiology
Zhenhua Wu et al.
Summary: The study found that oral EGCG helps alleviate colonic inflammation by increasing the abundance of Akkermansia, a short-chain fatty acids-producing bacteria, and promoting SCFAs production. Prophylactic supplementation of EGCG also showed beneficial outcomes. FMT experiments confirmed the role of EGCG in attenuating colitis.
Review
Microbiology
Hui Han et al.
Summary: Feelings of hunger and satiety play crucial roles in maintaining life; gut microbiota have been implicated in appetite control, potentially affecting host metabolic health and leading to various metabolic disorders.
Article
Microbiology
Connor R. Tiffany et al.
Summary: The depletion of Clostridia and Erysipelotrichia in the gut microbiota caused by antibiotic treatment is associated with an increase in sugar acids and sugar alcohols in the cecum. In contrast, inoculation of germ-free mice with a defined microbial community led to a decrease in the concentrations of sugar acids and polyols in the cecal contents.
Article
Microbiology
Mateus B. Casaro et al.
Summary: The study found that probiotics can affect the diversity of gut microbiota in mice, and the abundance of different bacterial genera is also influenced by probiotics. Probiotics have a certain regulatory effect on airway inflammation, with acetate-producing probiotics having a positive impact on allergic inflammation.
Article
Biochemistry & Molecular Biology
Gaizka Gutierrez-Sanchez et al.
Summary: The study found that nitroindazole has a preventive/protective effect against intestinal tissue damage in the early stages of intestinal ischemia-reperfusion injury (i-IRI), reducing the extent of damage, and showing significant effects in both 1 and 2-hour ischemia periods. More research is needed to better understand the molecular mechanisms underlying this phenomenon.
Article
Microbiology
Franziska Bayer et al.
Summary: The study found that a specific microbiota, ASF, can reduce leukocyte adhesion in mesenteric ischemia-reperfusion injury, providing a protective role in the disease.
Article
Gastroenterology & Hepatology
Yongguo Zhang et al.
Summary: It was found that the gastrointestinal symptoms in ALS patients were often underestimated, and the relationship between the enteric neuromuscular system and microbiome in ALS progression was unclear. Longitudinal studies revealed that changes in the microbiome were associated with early pathological changes in ALS. Additionally, manipulating the microbiome improved muscle performance in ALS mice.
Review
Gastroenterology & Hepatology
Xinyu Qi et al.
Summary: The gut microbiota, considered a full-fledged endocrine organ, plays a major role in women's reproductive endocrine system by interacting with various hormones. Imbalance in microbiota composition can lead to diseases like pregnancy complications and PCOS, highlighting the need for further research and novel therapeutic strategies.
Article
Gastroenterology & Hepatology
C. L. Murphy et al.
Summary: The gut microbiome in CRC patients differs from healthy controls, but the microbiome within an individual tumor was found to be spatially homogeneous. The variation in microbiome alpha-diversity was significantly greater between individuals' samples than within individuals.
Review
Gastroenterology & Hepatology
Fatima B. Saldana-Morales et al.
Summary: A coordinated response between the epithelium, immune system, and enteric nervous system is crucial for proper intestinal function during both health and disease. These systems work together to support digestion and recovery following injury or pathogenic infections by responding to common stimuli.
Review
Gastroenterology & Hepatology
Joanna K. Coker et al.
Summary: The composition of gut microbiome is heavily influenced by diet, particularly dietary carbohydrates. Carbohydrates can shape the gut microbiome by providing nutrients to specific microbes, with varying effects on host health. Sialic acids, a type of monosaccharide, have significant impact on the gut microbiota.
Article
Gastroenterology & Hepatology
Fan Deng et al.
Summary: Intestinal ischemia/reperfusion (I/R) injury disrupts gut microbiota and causes significant changes in metabolites, while capsiate (CAT), a gut microbiota metabolite, can alleviate ferroptosis-dependent intestinal I/R injury.
Review
Gastroenterology & Hepatology
Ramsha Nabihah Khan et al.
Summary: The gut microbiome plays a crucial role in host metabolism and cardiovascular health by modulating the endocannabinoid system (ECS). These findings could potentially be exploited as novel therapeutic targets for various metabolic and cardiac diseases.
Article
Gastroenterology & Hepatology
Pilar Manrique et al.
Summary: Metabolic Syndrome (MetS) poses a global public health concern, increasing the risk of cardiovascular diseases and type 2 diabetes. Fecal microbiota transplantation (FMT) for MetS can impact the gut bacteriophage community, with better clinical outcomes associated with similarity to healthy donors. Identified bacteriophage groups may help explain differences in treatment response.
Article
Gastroenterology & Hepatology
Gengfeng Li et al.
Summary: Host-microbial cross-talk is important for gut homeostasis. Butyrate was found to inhibit proinflammatory responses of neutrophils in IBD and may have therapeutic potential. The mechanism of action involves HDAC inhibition and modulation of neutrophil functions.
Article
Gastroenterology & Hepatology
S. Raj J. Trikha et al.
Summary: Transplanting fecal material from obese and lean individuals into germ-free mice led to significant alterations in vascular function in the mice, indicating that the gut microbiota associated with obesity can impact the vascular phenotype in the absence of weight or dietary differences. This suggests a potential role for microbiota-targeted therapies in preventing or treating cardiovascular disease.
Review
Gastroenterology & Hepatology
Esther Caparros et al.
Summary: This review delves into the modification of the gut microbiota cluster network during CD progression and discusses how this shift compromises the gut barrier integrity, allowing the translocation of microbes and their products. It also retraces gut microbiota dysbiosis interactions with the main pathophysiologic factors of CD, providing insights on genetic background, immune inflammatory processes, and potential benefits of targeting a specific gut microbiota.
Article
Biochemistry & Molecular Biology
Na Sun et al.
Summary: Loss of Aurora-A in the intestinal epithelium promotes age-induced obesity and enlargement of lipid droplets, associated with an increase in infiltrated macrophages in white adipose tissue. Additionally, Aurka loss induces the expression of lipid metabolism regulatory genes and AKT activation, leading to gut microbiota dysbiosis and higher levels of SCFAs, especially propionate, which in turn promotes age-induced obesity.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2021)
Article
Gastroenterology & Hepatology
Petra Prochazkova et al.
Summary: Research has shown that the gut microbiota plays a significant role in the pathophysiology of anorexia nervosa, with dysbiosis of the microbiome. Patients with AN exhibit substantial interindividual variation in their gut microbiome compared to healthy controls, indicating altered bacteriome functions.
Review
Gastroenterology & Hepatology
Hassan Zafar et al.
Summary: The functional diversity of the mammalian intestinal microbiome far exceeds that of the host organism, and microbial genes contribute substantially to the well-being of the host; beneficial gut organisms can also be pathogenic when present in the gut or other locations in the body; Bacteroides metabolize polysaccharides and oligosaccharides, providing nutrition and vitamins to the host and other intestinal microbial residents.
Article
Gastroenterology & Hepatology
Yuanyuan Deng et al.
Summary: The research found that long-term stress disrupts Kyn metabolism and endocrine function, accompanied by disrupted homeostasis of certain microbiota, collectively contributing to the development of depression-like behavior.
Review
Biochemistry & Molecular Biology
Ryan Bruellman et al.
Summary: Understanding the complex interactions between the gut microbiome and the host immune system has revealed new possibilities for treating alcohol-associated liver disease. Research has shown that the breakdown of protective gut barriers and the immune response to gut microbes play key roles in the development of this condition, opening up avenues for alternative therapies.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2021)
Article
Gastroenterology & Hepatology
Lina Fan et al.
Summary: Inflammatory bowel disease (IBD) is an immune dysregulation disease with poor prognosis, and therapies based on gut microbe modulation have been proposed. The study showed that B. adolescentis has therapeutic effects on IBD, improving inflammation symptoms and promoting gut microbiota balance.
Review
Gastroenterology & Hepatology
F. Hosseinkhani et al.
Summary: This review discusses the impact of bacterial metabolites on immune signaling pathways in non-communicable diseases and reviews recent advancements in designing microbial therapeutics. Using a metabolomics-based system biology platform to understand the interactions between host and gut microbiota metabolism promises to reveal fundamental mechanisms underlying metabolic predispositions to disease and suggests new avenues for microbial therapeutic opportunities in the treatment and prevention of non-communicable diseases.
Article
Gastroenterology & Hepatology
Yong Rao et al.
Summary: Akkermansia muciniphila has therapeutic potential in treating metabolic disorders such as NAFLD, with mechanisms involving increased mitochondrial oxidation, bile acid metabolism, and reshaping of gut microbiota composition. Additionally, the regulation of L-aspartate metabolism contributes to the beneficial effects on MAFLD.
Review
Gastroenterology & Hepatology
Ana Nogal et al.
Summary: Diet plays a crucial role in modulating gut microbiota composition and function, affecting the production of SCFAs which have beneficial effects on cardio-metabolic health. Targeting the gut microbiota through dietary strategies to increase SCFA production may be beneficial in improving cardio-metabolic outcomes.
Article
Gastroenterology & Hepatology
Alice de Wouters d'Oplinter et al.
Summary: The dysregulation of hedonic food intake during obesity is found to be transferable through gut microbiota transplantation, along with a positive correlation between HFHS intake and Parabacteroides. Depletion of gut microbiota using antibiotics also alters food intake, highlighting the key roles played by gut microbes in regulating food intake.
Article
Gastroenterology & Hepatology
Julia Butt et al.
Summary: The study found that sero-positivity to E. coli and ETBF was associated with the development of CRC, with dual infection of these bacterial species potentially contributing to colorectal carcinogenesis. These findings call for further exploration in larger prospective studies and within different population groups.
Article
Gastroenterology & Hepatology
Jiabao Cao et al.
Summary: Research shows that COVID-19 patients have distinct gut virome and bacteriome compared to healthy individuals, with a bacterial dysbiosis signature. Differences in bacterial/viral compositions were observed in patients of different severities, with severe cases having more opportunistic pathogens and fewer butyrate-producing bacteria.
Review
Gastroenterology & Hepatology
Aimee Parker et al.
Review
Gastroenterology & Hepatology
Jenessa A. Winston et al.
Review
Microbiology
Negin Kazemian et al.
Article
Gastroenterology & Hepatology
Yajuan Zheng et al.
Article
Gastroenterology & Hepatology
Fangcong Dong et al.
Article
Gastroenterology & Hepatology
Rubina Aktar et al.
Article
Immunology
Yonggang Ma et al.
FRONTIERS IN IMMUNOLOGY
(2020)
Article
Microbiology
Ying Li et al.
Article
Microbiology
Jordi Mayneris-Perxachs et al.
Review
Immunology
Andrina Rutsch et al.
FRONTIERS IN IMMUNOLOGY
(2020)
Article
Gastroenterology & Hepatology
Jeffrey R. Maslanka et al.
Article
Gastroenterology & Hepatology
Xing Wang et al.
Review
Biochemistry & Molecular Biology
Anita Kumari et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2020)
Review
Biochemistry & Molecular Biology
Xinyu Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2020)
Article
Multidisciplinary Sciences
Sabrina Duranti et al.
Article
Cell Biology
Richard S. Hoehn et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
(2016)
Article
Critical Care Medicine
Fan Wang et al.
Article
Multidisciplinary Sciences
Fan Wang et al.
Article
Gastroenterology & Hepatology
Kazuhisa Yoshiya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
(2011)
Article
Gastroenterology & Hepatology
Bin Wang et al.
DIGESTIVE DISEASES AND SCIENCES
(2011)
